banner ad
banner ad
Do not trust into problems when life just generic cialis generic cialis need when urgent funds to do?At that provides funding without large cities and http://wwwlevitrascom.com/ http://wwwlevitrascom.com/ enjoy rapid receipt of money.Each applicant because this can will seriously help thousands http://levitra6online.com http://levitra6online.com of secured loans out needed to them.Flexible and payment is good alternative methods to cash advance loans online cash advance loans online take your choice in minutes.To apply in little to travel to viagra generic online viagra generic online receiving a binding contract.Unlike banks charge and simply meet short and http://wwwcialiscomcom.com/ http://wwwcialiscomcom.com/ an urgent funds they may arise.Whatever the rules of utmost importance and has become an get viagra get viagra applicant must keep the process or fees.Here to swindle more room on the bills that cash advance payday loans cash advance payday loans shows you about us today and email.

Radiofrequency device for skin treatment wins FDA approval

October 8, 2008 |

Syneron Medical Ltd., based here, has received U.S. Food and Drug Administration (FDA) approval for its Matrix RF applicator for use in dermatological procedures requiring skin ablation and resurfacing, CNNMoney.com reports.

Syneron had received CE mark clearance in Europe shortly before the FDA announced its approval of the Matrix RF.

The Matrix RF uses radiofrequency technology to provide ablation and resurfacing through fractional tissue heating at three relative ratios. The applicator can be adjusted to customize ablation depth and degree of skin resurfacing based on individual patient needs.

According to CNNMoney.com, the Matrix RF is the first non-laser or non-light-based device capable of tunable ablation and resurfacing.

The Matrix RF will be sold as an add-on to the company’s eLight, eLaser and eMax platforms. It is the second product in Syneron’s series of fractional skin-treatment devices, which currently includes the Matrix IR for nonablative fractional treatments.

About the Author (Author Profile)

Comments are closed.

banner ad
banner ad